Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis-Reference-Cited by-同舟云学术

Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis

Published:2023-03 Issue:2 Volume:10 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Álvarez-Velasco Rodrigo¹,Dols-Icardo Oriol¹,El Bounasri Shaima¹,López-Vilaró Laura¹,Trujillo Juan Carlos¹,Reyes-Leiva David¹,Suárez-Calvet Xavier¹,Cortés-Vicente Elena¹,Illa Isabel¹,Gallardo Eduard¹

Affiliation:

1. From the Neuromuscular Diseases Unit (R.Á.-V., D.R.-L., E.C.-V., I.I.), Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona; Department of Medicine (R.Á.-V., D.R.-L.), Universitat Autónoma de Barcelona; Memory Unit (O.D.-I., S.E.B.), Neurology Department and Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED) (O.D.-I., S.E.B.), Madrid;...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200085

Reference26 articles.

1. Myasthenia gravis: subgroup classification and therapeutic strategies

2. Histological Typing of Tumours of the Thymus

3. Inter-relationship among myasthenia gravis, WHO histology, and Masaoka clinical stage and effect on surgical methods in patients with thymoma: a retrospective cohort study

4. Thymoma associated with autoimmune diseases: 85 cases and literature review

5. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new gene signature associated with disulfidptosis that forecasts myasthenia gravis and suggests infiltration of immune microenvironment in thymoma patients;Heliyon;2024-04

2. Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas;Cancers;2023-12-29

3. Neurologic Complications of Cancer Immunotherapy;Current Oncology;2023-06-19